Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to: "Comment on: risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors".

Eye (London, England)·2026
Same author

Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic Uveitis.

American journal of ophthalmology·2026
Same author

Immune Checkpoint Inhibitor-Associated Uveitis: Insights From Comparative Analyses Across Malignancies and Drug Classes.

American journal of ophthalmology·2026
Same author

Efficacy of En Face Optical Coherence Tomography Minimum Intensity Projection in Evaluating Inflammatory Retinal Vascular Changes.

American journal of ophthalmology·2026
Same author

En Face Optical Coherence Tomography Imaging as a Structural Surrogate for Posterior Pole Inflammatory Retinal Vascular Activity.

American journal of ophthalmology·2026
Same author

Choroidal Vessel Thickness Changes on Indocyanine Green Angiography After Scleral Windows for Uveal Effusion Syndrome.

Journal of vitreoretinal diseases·2026

Related Experiment Video

Updated: Dec 16, 2025

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
06:20

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

2.4K

Lymphoma masquerading as occlusive retinal vasculitis: A case study.

Scott J Sonne1, Wen-Shi Shieh2, Sunil K Srivastava3

  • 1Saint Louis University School of Medicine, St. Louis, MO, USA.

American Journal of Ophthalmology Case Reports
|July 3, 2020
PubMed
Summary

Retinal lymphoma can mimic occlusive retinal vasculitis without vitritis, responding temporarily to intravitreal dexamethasone implant (IVDI). Early diagnosis and multimodal therapy are crucial for managing this rare presentation.

Keywords:
Intravitreal dexamethasoneLymphomaOcclusive vasculitisOzurdexRetinal vasculitisUveitis

More Related Videos

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.7K
Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
08:22

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Published on: January 12, 2022

4.9K

Related Experiment Videos

Last Updated: Dec 16, 2025

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
06:20

Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor

Published on: January 12, 2024

2.4K
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
06:15

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

1.7K
Application of Optical Coherence Tomography to a Mouse Model of Retinopathy
08:22

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

Published on: January 12, 2022

4.9K

Area of Science:

  • Ophthalmology
  • Oncology
  • Retinal Diseases

Background:

  • Retinal lymphoma is a rare intraocular malignancy.
  • It can present with diverse clinical features, sometimes mimicking inflammatory conditions.
  • Early and accurate diagnosis is critical for effective management.

Observation:

  • A 66-year-old male presented with vision loss and retinal vasculitis without vitritis.
  • Initial treatments with systemic steroids and cyclophosphamide were ineffective.
  • Intravitreal dexamethasone implant (IVDI) led to significant visual and clinical improvement, masking the underlying lymphoma.

Findings:

  • The patient later developed lymphomatous infiltration in the subretinal space and corpus callosum.
  • The initial presentation of retinal vasculitis was responsive to IVDI, highlighting a potential diagnostic challenge.
  • Multimodal therapy including intravitreal methotrexate, rituximab, and autologous stem cell transplant led to sustained disease remission.

Implications:

  • Retinal lymphoma should be considered in cases of unexplained retinal vasculitis, even without vitritis.
  • The temporary response to IVDI can mask lymphoma, necessitating thorough systemic evaluation.
  • Aggressive and tailored treatment strategies are essential for managing ocular lymphoma.